Depomed (NASDAQ: DEPO) announced that its Board of Directors, after careful consideration and with the assistance of its independent financial ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Hot Corp. News Hot M&A Management Comments Mergers and Acquisitions

Janney Capital Downgrades DepoMed Inc (DEPO) to NeutralJuly 30, 2015 9:28 AM RBC Capital Downgrades DepoMed Inc (DEPO) to Sector PerformJuly 30, 2015 6:46 AM Depomed (DEPO) Tops Q2 EPS by 27c; Boosts FY15 OutlookJuly 29, 2015 4:07 PM Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 GuidanceJuly 29, 2015 4:04 PM Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plcJuly 29, 2015 4:03 PM Depomed to Report Second Quarter Fiscal Year 2015 Financial Results on Wednesday, July 29, 2015July 29, 2015 8:00 AM